ZA926191B - Purified immunoglobulin. - Google Patents

Purified immunoglobulin.

Info

Publication number
ZA926191B
ZA926191B ZA926191A ZA926191A ZA926191B ZA 926191 B ZA926191 B ZA 926191B ZA 926191 A ZA926191 A ZA 926191A ZA 926191 A ZA926191 A ZA 926191A ZA 926191 B ZA926191 B ZA 926191B
Authority
ZA
South Africa
Prior art keywords
antibody
column
prepn
cdw52
purified
Prior art date
Application number
ZA926191A
Other languages
English (en)
Inventor
Paul Ian Nicholas Ramage
Geoffrey Allen
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10683866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA926191(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA926191B publication Critical patent/ZA926191B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA926191A 1990-10-17 1991-10-16 Purified immunoglobulin. ZA926191B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022547A GB9022547D0 (en) 1990-10-17 1990-10-17 Purified immunoglobulin

Publications (1)

Publication Number Publication Date
ZA926191B true ZA926191B (en) 1993-04-16

Family

ID=10683866

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA926191A ZA926191B (en) 1990-10-17 1991-10-16 Purified immunoglobulin.
ZA918259A ZA918259B (en) 1990-10-17 1991-10-16 Purified immunoglobulin.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA918259A ZA918259B (en) 1990-10-17 1991-10-16 Purified immunoglobulin.

Country Status (29)

Country Link
US (1) US5644036A (es)
EP (1) EP0504363B2 (es)
JP (1) JP2638680B2 (es)
KR (2) KR960015399B1 (es)
AT (2) ATE162552T1 (es)
AU (3) AU658926B2 (es)
BE (1) BE1004226A5 (es)
BR (1) BR1100358A (es)
CA (1) CA2069481C (es)
CH (2) CH681455A5 (es)
DE (1) DE69128774T3 (es)
DK (1) DK0504363T4 (es)
ES (2) ES2081742B1 (es)
FI (2) FI110003B (es)
FR (2) FR2668164A1 (es)
GB (2) GB9022547D0 (es)
GR (3) GR910100425A (es)
HU (1) HUT64601A (es)
IE (1) IE913560A1 (es)
IL (3) IL99761A0 (es)
IT (1) IT1250064B (es)
LU (1) LU88122A1 (es)
MX (1) MX9203794A (es)
MY (2) MY119030A (es)
NZ (2) NZ240247A (es)
PT (2) PT99248B (es)
TW (1) TW283710B (es)
WO (1) WO1992007084A1 (es)
ZA (2) ZA926191B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
DK0610447T3 (da) * 1991-10-15 1999-08-23 Btg Int Ltd CDw52-specifikt antistof til behandling af T-cellemedieret inflammation af leddene
GB9125768D0 (en) * 1991-12-04 1992-02-05 Hale Geoffrey Therapeutic method
GB9300501D0 (en) * 1993-01-09 1993-03-03 Wellcome Found Purification of immunoglobulin
EP0841942B2 (fr) † 1995-08-01 2007-12-12 Sanofi Pasteur Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu
US6090382A (en) * 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
HU228630B1 (en) 1996-02-09 2013-04-29 Abbott Biotech Ltd Use of human anti bodies that bind human tnf-alpha and process for inhibiting of human tnf-alpha activity
GB9603256D0 (en) * 1996-02-16 1996-04-17 Wellcome Found Antibodies
US20030023043A1 (en) * 2000-03-02 2003-01-30 Kazuhisa Uchida Method of separating and purifying protein
EP3088412B1 (en) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method
DK1714982T3 (da) * 2001-06-05 2009-05-04 Genetics Inst Llc Fremgangsmåde til rensning af stærkt anioniske proteiner
GB0220894D0 (en) * 2002-09-09 2002-10-16 Millipore Uk Ltd Method of separation
ES2626268T3 (es) 2002-09-11 2017-07-24 Chugai Seiyaku Kabushiki Kaisha Método de purificación de proteínas
WO2004035618A2 (en) 2002-10-15 2004-04-29 Intercell Ag Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
JP2007515492A (ja) * 2003-12-22 2007-06-14 ジェンザイム コーポレイション 糖尿病の抗ｃｄ５２抗体治療法
KR101660575B1 (ko) * 2005-03-11 2016-09-27 와이어쓰 엘엘씨 약한 분배성 크로마토그래피법
TWI564021B (zh) 2008-04-11 2017-01-01 Chugai Pharmaceutical Co Ltd Repeated binding of antigen to antigen binding molecules
AU2010248935B2 (en) 2009-05-13 2016-12-15 Genzyme Corporation Methods and compositions for treating lupus
KR101537840B1 (ko) 2009-05-13 2015-07-22 젠자임 코포레이션 항-인간 ｃｄ52 면역글루불린
US20130178608A1 (en) * 2009-12-29 2013-07-11 Samir Kulkarni Protein purification by ion exchange
ES2671347T3 (es) 2010-06-21 2018-06-06 Kyowa Hakko Kirin Co., Ltd. Procedimiento para purificar una proteína que utiliza un aminoácido
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
MX365235B (es) 2010-11-30 2019-05-28 Chugai Pharmaceutical Co Ltd Molécula de unión a antígeno capaz de unir repetidamente a la pluralidad de moléculas de antígeno.
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
GB201109238D0 (en) * 2011-06-01 2011-07-13 Antitope Ltd Antibodies
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
KR20150043523A (ko) 2012-09-02 2015-04-22 애브비 인코포레이티드 단백질 불균일성의 제어 방법
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
AR095199A1 (es) 2013-03-15 2015-09-30 Genzyme Corp Anticuerpos anti-cd52
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
BR112016014824A2 (pt) 2013-12-27 2017-09-19 Chugai Pharmaceutical Co Ltd Método para purificar anticorpo que tem ponto isoelétrico baixo
CA2963760A1 (en) 2014-12-19 2016-06-23 Yoshinao Ruike Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
JP6823596B2 (ja) 2015-07-31 2021-02-03 中外製薬株式会社 アニオン性ポリマーによる抗体を含有する組成物の精製方法
US10688412B2 (en) 2016-07-25 2020-06-23 Cehpalon, Inc. Affinity chromatography wash buffer
CA3026050A1 (en) 2016-08-05 2018-02-08 Chugai Seiyaku Kabushiki Kaisha Composition for prophylaxis or treatment of il-8 related diseases
JP7273142B2 (ja) 2019-03-29 2023-05-12 旭化成メディカル株式会社 タンパク質の精製方法
JP7295943B2 (ja) 2019-04-08 2023-06-21 旭化成メディカル株式会社 タンパク質含有溶液精製用ポリアミド媒体及びその製造方法
CN113906042A (zh) 2019-04-10 2022-01-07 中外制药株式会社 用于纯化fc区修饰抗体的方法
WO2022260091A1 (ja) 2021-06-10 2022-12-15 三菱ケミカル株式会社 合成吸着剤、抗体の精製方法及び抗体の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
DE68909441T2 (de) * 1988-02-12 1994-02-10 British Tech Group Modifizierte Antikörper.

Also Published As

Publication number Publication date
FI110003B (fi) 2002-11-15
FR2677997A1 (fr) 1992-12-24
PT100988B (pt) 1999-08-31
ES2112865T5 (es) 2007-09-16
CA2069481A1 (en) 1992-04-18
AU658926B2 (en) 1995-05-04
MX9203794A (es) 1992-07-01
AU2532192A (en) 1993-02-11
BR1100358A (pt) 2000-03-28
CA2069481C (en) 2003-07-29
AU8729491A (en) 1992-05-20
DE69128774T3 (de) 2007-08-16
FI110002B (fi) 2002-11-15
AU716402B2 (en) 2000-02-24
IT1250064B (it) 1995-03-30
GR910100425A (el) 1992-09-25
DE69128774D1 (de) 1998-02-26
ZA918259B (en) 1993-04-16
TW283710B (es) 1996-08-21
LU88122A1 (fr) 1993-03-15
HUT64601A (en) 1994-01-28
DK0504363T4 (da) 2007-05-29
MY119030A (en) 2005-03-31
US5644036A (en) 1997-07-01
FI922380A (fi) 1992-05-25
NZ240247A (en) 1994-03-25
FI922824A (fi) 1992-06-17
PT99248B (pt) 1999-04-30
IL102726A0 (en) 1993-01-31
AU649078B2 (en) 1994-05-12
ATE162552T1 (de) 1998-02-15
HU9202000D0 (en) 1992-10-28
KR920703108A (ko) 1992-12-17
ES2081742A1 (es) 1996-03-01
PT100988A (pt) 1994-02-28
MY136210A (en) 2008-08-29
GR3026588T3 (en) 1998-07-31
GR920100471A (el) 1994-06-30
IL99761A0 (en) 1992-08-18
EP0504363B1 (en) 1998-01-21
CH681305A5 (es) 1993-02-26
CH681455A5 (es) 1993-03-31
ES2081742B1 (es) 1996-10-01
EP0504363A1 (en) 1992-09-23
DE69128774T2 (de) 1998-06-04
FR2668164B1 (es) 1995-04-14
ES2112865T3 (es) 1998-04-16
AU7024294A (en) 1995-01-05
DK0504363T3 (da) 1998-09-21
WO1992007084A1 (en) 1992-04-30
JP2638680B2 (ja) 1997-08-06
NZ244114A (en) 1995-06-27
GB9209529D0 (en) 1992-07-01
ITRM910788A1 (it) 1993-04-16
BE1004226A5 (fr) 1992-10-13
KR100193314B1 (ko) 1999-06-15
IL102726A (en) 2002-08-14
AU4521897A (en) 1998-02-12
GB2253397A (en) 1992-09-09
FR2668164A1 (fr) 1992-04-24
PT99248A (pt) 1993-06-30
EP0504363B2 (en) 2007-02-07
IE913560A1 (en) 1992-04-22
FI922380A0 (fi) 1992-05-25
KR960015399B1 (ko) 1996-11-13
FI922824A0 (fi) 1992-06-17
ITRM910788A0 (it) 1991-10-16
ATA900791A (de) 1996-06-15
JPH05504579A (ja) 1993-07-15
GB9022547D0 (en) 1990-11-28

Similar Documents

Publication Publication Date Title
TW283710B (es)
MX9603637A (es) Purificacion de anticuerpo.
CA1208130A (en) ULTRAPURIFICATION OF FACTOR VIII
EP0185034A4 (es)
AU3598284A (en) Factor viii:c purification
EP0239565A3 (en) Method of and apparatus for separating proteins
IL88118A (en) Ion-exchange chromatographic method of purifying proteins
Dimitrijevic et al. Purification and characterization of an estrogen-binding peroxidase from human fetuses
HK1007747A1 (en) Interferon purification process
von Bahr-Lindström et al. Analytical and Preparative Applications of High-Performance Liquid Chromatography. Comparisons with Other Methods
GB9001593D0 (en) Thiophilic absorbents
FR2411202A1 (fr) Procede d'extraction et de purification de la globuline transporteur d'hormones thyroidiennes tbg